COST-EFFECTIVENESS OF DONEPEZIL IN THE TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE: AN UPDATE

被引:0
|
作者
Chyr, L. C. [1 ]
Yapici, H. O. [1 ]
Padula, W., V [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
关键词
D O I
10.1016/j.jval.2018.04.1399
中图分类号
F [经济];
学科分类号
02 ;
摘要
PND26
引用
收藏
页码:S206 / S206
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease
    Neumann, PJ
    Hermann, RC
    Kuntz, KM
    Araki, SS
    Duff, SB
    Leon, J
    Berenbaum, PA
    Goldman, PA
    Williams, LW
    Weinstein, MC
    NEUROLOGY, 1999, 52 (06) : 1138 - 1145
  • [2] Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
    Lopez-Bastida, Julio
    Hart, Warren
    Garcia-Perez, Lidia
    Linertova, Renata
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (02) : 399 - 407
  • [3] COST-EFFECTIVENESS OF DONEPEZIL IN ALZHEIMER'S DISEASE IN SWEDEN
    Mesterton, J.
    By, A.
    Sandelin, R.
    Jonsson, L.
    VALUE IN HEALTH, 2009, 12 (07) : A369 - A369
  • [4] COST-EFFECTIVENESS OF SCREENING AND TREATMENT OF ALZHEIMER'S DISEASE WITH DONEPEZIL IN THE UNITED KINGDOM
    Getsios, D.
    Blume, S.
    Ishak, K. J.
    MacLaine, G.
    VALUE IN HEALTH, 2009, 12 (03) : A191 - A191
  • [5] Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease
    Teipel, Stefan J.
    Ewers, Michael
    Reisig, Veronika
    Schweikert, Bernd
    Hampel, Harald
    Happich, Michael
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 257 (06) : 330 - 336
  • [6] Long-term cost-effectiveness of donepezil for the treatment of Alzheimer’s disease
    Stefan J. Teipel
    Michael Ewers
    Veronika Reisig
    Bernd Schweikert
    Harald Hampel
    Michael Happich
    European Archives of Psychiatry and Clinical Neuroscience, 2007, 257 : 330 - 336
  • [7] COST-EFFECTIVENESS OF ADUCANUMAB VERSUS DONEPEZIL FOR PATIENTS WITH EARLY ALZHEIMER'S DISEASE
    Xiong, X.
    Li, M.
    Lu, Z. K.
    VALUE IN HEALTH, 2023, 26 (06) : S85 - S85
  • [8] The cost-effectiveness of donepezil and rivastigmine in the treatment of Alzheimer's disease in Thailand private hospital
    Pattanaprateep, O
    Phongchareonsuk, P
    Chaikledkaew, U
    VALUE IN HEALTH, 2005, 8 (03) : 314 - 315
  • [9] The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease:: A Markov model
    Jönsson, L
    Lindgren, P
    Wimo, A
    Jönsson, B
    Winblad, B
    CLINICAL THERAPEUTICS, 1999, 21 (07) : 1230 - 1240
  • [10] Cost-effectiveness of memantine in moderate-tosevere Alzheimer's disease patients receiving donepezil
    Weycker, Derek
    Taneja, Charu
    Edelsberg, John
    Erder, M. Haim
    Schmittc, Frederick A.
    Setyawan, Juliana
    Oster, Gerry
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 1187 - 1197